These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15147951)

  • 21. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
    Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
    J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
    Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
    Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase.
    Blanchard JE; Elowe NH; Huitema C; Fortin PD; Cechetto JD; Eltis LD; Brown ED
    Chem Biol; 2004 Oct; 11(10):1445-53. PubMed ID: 15489171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and inhibition of SARS-coronavirus main protease.
    Liang PH
    Curr Top Med Chem; 2006; 6(4):361-76. PubMed ID: 16611148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
    Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
    Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid chromatographic enzymatic studies with on-line Beta-secretase immobilized enzyme reactor and 4-(4-dimethylaminophenylazo) benzoic acid/5-[(2-aminoethyl) amino] naphthalene-1-sulfonic acid peptide as fluorogenic substrate.
    De Simone A; Seidl C; Santos CA; Andrisano V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():108-14. PubMed ID: 24590190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
    Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris.
    Nguyen TT; Woo HJ; Kang HK; Nguyen VD; Kim YM; Kim DW; Ahn SA; Xia Y; Kim D
    Biotechnol Lett; 2012 May; 34(5):831-8. PubMed ID: 22350287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
    Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
    Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
    Pennington MW; Thornberry NA
    Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.
    Fan K; Wei P; Feng Q; Chen S; Huang C; Ma L; Lai B; Pei J; Liu Y; Chen J; Lai L
    J Biol Chem; 2004 Jan; 279(3):1637-42. PubMed ID: 14561748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods.
    Kaeppler U; Stiefl N; Schiller M; Vicik R; Breuning A; Schmitz W; Rupprecht D; Schmuck C; Baumann K; Ziebuhr J; Schirmeister T
    J Med Chem; 2005 Nov; 48(22):6832-42. PubMed ID: 16250642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
    Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
    Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fluorogenic substrate as quantitative in vivo reporter to determine protein expression and folding of tobacco etch virus protease in Escherichia coli.
    Kraft M; Radke D; Wieland GD; Zipfel PF; Horn U
    Protein Expr Purif; 2007 Apr; 52(2):478-84. PubMed ID: 17188891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New intramolecularly quenched fluorogenic peptide substrates for the study of the kinetic specificity of papain.
    García-Echeverría C; Rich DH
    FEBS Lett; 1992 Feb; 297(1-2):100-2. PubMed ID: 1551413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A continuous assay for foot-and-mouth disease virus 3C protease activity.
    Jaulent AM; Fahy AS; Knox SR; Birtley JR; Roqué-Rosell N; Curry S; Leatherbarrow RJ
    Anal Biochem; 2007 Sep; 368(2):130-7. PubMed ID: 17631855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant.
    Akaji K; Konno H; Onozuka M; Makino A; Saito H; Nosaka K
    Bioorg Med Chem; 2008 Nov; 16(21):9400-8. PubMed ID: 18845442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of protease inhibitors by a fast fluorimetric assay.
    Doti N; Raimondo D; Sabatella M; Ruvo M
    Mol Biotechnol; 2013 Jun; 54(2):283-91. PubMed ID: 22684771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
    Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
    ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease.
    Wong KB; Wan DC; Chow HF
    Hong Kong Med J; 2014 Aug; 20 Suppl 4():18-21. PubMed ID: 25224113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.